Lewandowski Krzysztof, Hincz Piotr, Grzesiak Mariusz, Cajdler-Łuba Agata, Salata Ireneusz, Wilczyński Jan, Lewiński Andrzej
Department of Endocrinology, Polish Mother Memorial Research Institute, Medical University of Lodz, Poland.
Ginekol Pol. 2010 Jul;81(7):537-40.
A 32-year-old Caucasian was admitted at 14 weeks of gestation with hypotension and weight loss. Family members noted that she appeared "tired" prior to pregnancy Past medical history included primary hypothyroidism treated with thyroxine (100 microg/day). She had a healthy daughter aged 2.5 years who had been born small for gestational age. At about 8 weeks of gestation she started to vomit several times a day. She was treated with antiemetics and intravenous fluids. Following discharge she remained nauseated, weak and lightheaded and lost about 8 kg of weight. After readmission she appeared ill and dehydrated, BMI 16.6 kg/m2, BP 90/60 mmHg supine, 70/50 mmHg upright (with faint-like sensation), normal heart sounds, chest clinically clear, abdomen soft and not tender Investigations revealed severe hyponatraemia (sodium 112 mmol/L), normal potassium level 4.3 mmol/L, normal renal function, TSH 1.31 microIU/mL (reference range (RR): 0.27-4.2), freeT4 1.99 ng/dL (RR: 0.93-1.7), freeT3 3.29 pg/mL (RR: 2.57-4.43), anti-TPO antibodies 467 IU/mL (RR: <34)). She was hyperpigmented, hypotensive and hyponatraemic despite rehydration. Cortisol & ACTH, followed by a 250 microg short Synacthen test were requested and revealed peak cortisol response of 17 nmol/L (RR: above 550 nmol/l) as well as high baseline ACTH (969 pg/mL, RR: 0-46 pg/mL). She was started on hydrocortisone and felt tremendously better A diagnosis of Addisons disease was made (in view of hypothyroidism as a part of Autoimmune Polyglandular Syndrome type II). She was discharged on hydrocortisone and fludrocortisone replacement. Further during her pregnancy there was about two-week foetal growth delay. She, however delivered a healthy female infant at 36 weeks of gestation.
New onset Addison's disease is rare in pregnancy but may present with prolonged vomiting and weight loss. Therefore adrenal failure should be included in the differential diagnosis of hyperemesis gravidarum.
一名32岁的白种女性在妊娠14周时因低血压和体重减轻入院。家庭成员指出,她在怀孕前就显得“疲惫”。既往病史包括用甲状腺素(100微克/天)治疗的原发性甲状腺功能减退症。她有一个2.5岁的健康女儿,出生时小于孕周。妊娠约8周时,她开始每天呕吐数次。她接受了止吐药和静脉补液治疗。出院后,她仍感到恶心、虚弱和头晕,体重减轻了约8公斤。再次入院后,她看起来病恹恹的且脱水,体重指数(BMI)为16.6千克/平方米,仰卧位血压90/60毫米汞柱,直立位70/50毫米汞柱(有晕厥感),心音正常,胸部临床检查清晰,腹部柔软无压痛。检查发现严重低钠血症(血钠112毫摩尔/升),血钾水平正常为4.3毫摩尔/升,肾功能正常,促甲状腺激素(TSH)1.31微国际单位/毫升(参考范围(RR):0.27 - 4.2),游离甲状腺素(freeT4)1.99纳克/分升(RR:0.93 - 1.7),游离三碘甲状腺原氨酸(freeT3)3.29皮克/毫升(RR:2.57 - 4.43),抗甲状腺过氧化物酶(anti - TPO)抗体467国际单位/毫升(RR:<34)。尽管进行了补液,她仍有色素沉着、低血压和低钠血症。检测了皮质醇和促肾上腺皮质激素(ACTH),随后进行了250微克短效促肾上腺皮质激素试验,结果显示皮质醇峰值反应为17纳摩尔/升(RR:高于550纳摩尔/升)以及高基线ACTH(969皮克/毫升,RR:0 - 46皮克/毫升)。她开始服用氢化可的松后感觉好多了。诊断为艾迪生病(鉴于甲状腺功能减退是自身免疫性多内分泌腺综合征II型的一部分)。她出院时接受氢化可的松和氟氢可的松替代治疗。在她怀孕期间,胎儿生长有大约两周的延迟。然而,她在妊娠36周时分娩了一名健康的女婴。
妊娠期间新发艾迪生病罕见,但可能表现为持续性呕吐和体重减轻。因此,肾上腺功能衰竭应纳入妊娠剧吐的鉴别诊断。